OptiBiotix Health (LON:OPTI) Share Price Passes Below 50 Day Moving Average – Here’s What Happened

OptiBiotix Health Plc (LON:OPTI)’s stock price crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 6.05 and traded as low as GBX 5.50. OptiBiotix Health shares last traded at GBX 6, with a volume of 128,541 shares.

OptiBiotix Health Stock Down 0.3%

The company has a fifty day simple moving average of GBX 6.05 and a 200-day simple moving average of GBX 5.99. The firm has a market cap of £6.18 million, a P/E ratio of -1.56 and a beta of 1.85.

OptiBiotix Health (LON:OPTI) last posted its quarterly earnings data on Thursday, May 28th. The company reported GBX (3.84) EPS for the quarter. OptiBiotix Health had a negative return on equity of 52.92% and a negative net margin of 333.62%.The company had revenue of GBX 117 million during the quarter.

Insider Transactions at OptiBiotix Health

In other news, insider David Blain bought 158,965 shares of OptiBiotix Health stock in a transaction that occurred on Thursday, May 28th. The stock was bought at an average cost of GBX 6 per share, with a total value of £9,537.90. Corporate insiders own 26.79% of the company’s stock.

About OptiBiotix Health

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.